Single nucleotide polymorphisms in the multidrug resistance 1 gene in Korean epileptics

Seizure

Volumn 15, Issue 1, 2006, Pages 67-72

  Kim, Young Ok ^a   Kim, Myeong Kyu ^a   Woo, Young Jong ^a   Lee, Min Cheol ^a   Kim, Jin Hee ^a   Park, Ki Won ^b   Kim, Eun Young ^c   Roh, Young Il ^d   Kim, Chan Jong ^a  

^a Chonnam National University Medical School   (South Korea)

^b Department of Pediatrics   (South Korea)

^c Gwangju Christian Hospital   (South Korea)

^d Chosun University   (South Korea)

Author keywords

Drug resistant epilepsy; MDR1; Single nucleotide polymorphisms

Indexed keywords

MULTIDRUG RESISTANCE PROTEIN 1;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ARTICLE; CHILD; CONTROLLED STUDY; DRUG RESISTANCE; DRUG RESPONSE; EPILEPSY; EXON; FEMALE; FREQUENCY ANALYSIS; GENE FREQUENCY; GENOTYPE; HAPLOTYPE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE; EPILEPSY; EXONS; FEMALE; GENE FREQUENCY; GENES, MDR; GENOTYPE; HAPLOTYPES; HUMANS; KOREA; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 30744472610     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2005.11.001     Document Type: Article

References (27)

1. G. Regesta P. Tanganelli Clinical aspects and biological bases of drug-resistant epilepsies. Epilepsy Res 34: 1999; 109-122.
2. F. Semah M.C. Picot C. Adam et al. Is the underlying cause of epilepsy a major prognostic factor for recurrence? Neurology 51: 1998 1256-1262.
3. A. Siddiqui R. Kerb M.E. Weale et al. Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. N Engl J Med 348: 2003; 1442-1448.
4. S.M. Sisodiya Mechanisms of antiepileptic drug resistance. Curr Opin Neurol 16: 2003; 197-201.
5. J.A. Johnson Pharmacogenetics: Potential for individualized drug therapy through genetics. Trends Genet 19: 2003; 660-666.
6. W. Loscher H. Potschka Role of multidrug transporters in pharmacoresistance to antiepileptic drugs. J Pharmacol Exp Ther 301: 2002; 7-14.
7. H. Potschka M. Fedrowitz W. Loscher P-glycoprotein and multidrug resistance-associated protein are involved in the regulation of extracellular levels of the major antiepileptic drug carbamazepine in the brain. Neuroreport 12: 2001; 3557-3560.
8. H. Potschka W. Loscher In vivo evidence for P-glycoprotein-mediated transport of phenytoin at the blood-brain barrier of rats Epilepsia 42: 2001; 1231-1240.
9. H. Potschka M. Fedrowitz W. Loscher P-Glycoprotein-mediated efflux of phenobarbital, lamotrigine, and felbamate at the blood-brain barrier: evidence from microdialysis experiments in rats. Neurosci Lett 327: 2002; 173-176.
10. R.B. Kim MDR1 single nucleotide polymorphisms: Multiplicity of haplotypes and functional consequences Pharmacogenetics 12: 2002; 425-427.
11. T. Illmer U.S. Schuler C. Thiede et al. MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients Cancer Res 62: 2002; 4955-4962.
12. S. Hoffmeyer O. Burk O. von Richter et al. Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA 97: 2000; 3473-3478.
13. N.C. Tan S.E. Heron I.E. Scheffer et al. Failure to confirm association of a polymorphism in ABCB1 with multidrug-resistant epilepsy Neurology 63: 2004; 1090-1092.
14. G.J. Sills R. Mohanraj E. Butler et al. Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment. Epilepsia 46: 2005; 643-647.
15. M. Tanabe I. Ieiri N. Nagata et al. Expression of P-glycoprotein in human placenta: Relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. J Pharmacol Exp Ther 297: 2001; 1137-1143.
16. K. Tang S.M. Ngoi P.C. Gwee et al. Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations. Pharmacogenetics 12: 2002; 437-450.
17. M.L. Bernal B. Sinues A. Fanlo E. Mayayo Frequency distribution of C3435T mutation in exon 26 of the MDR1 gene in a Spanish population. Ther Drug Monit 25: 2003; 107-111.
18. L. Excoffier M. Slatkin Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 12: 1995; 921-927.
19. A.H. Schinkel E. Wagenaar C.A. Mol L. van Deemter P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J Clin Invest 97: 1996; 2517-2524.
20. O. Fardel V. Lecureur A. Guillouzo The P-glycoprotein multidrug transporter. Gen Pharmacol 27: 1996; 1283-1291.
21. S.M. Dombrowski S.Y. Desai M. Marroni et al. Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy. Epilepsia 42: 2001; 1501-1506.
22. E. Aronica J.A. Gorter G.H. Jansen et al. Expression and cellular distribution of multidrug transporter proteins in two major causes of medically intractable epilepsy: Focal cortical dysplasia and glioneuronal tumors. Neuroscience 118: 2003; 417-429.
23. A. Lazarowski F. Lubieniecki S. Camarero et al. Multidrug resistance proteins in tuberous sclerosis and refractory epilepsy. Pediatr Neurol 30: 2004; 102-106.
24. M.F. Fromm The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humans. Adv Drug Deliv Rev 54: 2002; 1295-1310.
25. D.B. Goldstein Islands of linkage disequilibrium. Nat Genet 29: 2001; 109-111.
26. F. Zimprich R. Sunder-Plassmann E. Stogmann et al. Association of an ABCB1 gene haplotype with pharmacoresistance in temporal lobe epilepsy. Neurology 63: 2004; 1087-1089.
27. C.C. Hung J.J. Tai C.J. Lin M.J. Lee H.H. Liou Complex haplotypic effects of the ABCB1 gene on epilepsy treatment response Pharmacogenomics 6: 2005; 411-417.